��躰�肽𨯙嚙踝蕭�椬��㮖����𠺪蕭��辷蕭
��躰�頣蕭皛抵�䈑蕭嚙踝蕭膌见�躰�肽𨯙
��躰�肽𨯙嚙踝蕭颲瑁𨯙�𢥫嚙質�嚙踢�𧶏蕭薳��𨯙
��躰釭嚙賢��𨯙嚙賡ㄤ��躰釭嚙賭�對蕭嚙�
��躰釭嚙賢��𨯙嚙踝蕭蒺矋蕭嚙賣���辷蕭
��躰�頣蕭嚙質𨯙��鞱�矋蕭��躰�肽𨯙嚙踢岡芾働嚙�
��躰�頣蕭皛抵�䈑蕭嚙踝蕭嚙賢�磰𨯙嚙踢﹜���躰�肽𨯙��躰�肽𨯙
嚙賭麩��躰�肽𨯙嚙賭�𡑒𨯙��躰�肽𨯙��躰�肽𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踝蕭��躰�頣蕭�迚�𨯙
��躰�肽𨯙嚙踝蕭嚙踢�佅嚙賢�躰�肽𨯙嚙踝蕭�迚�𨯙
��躰�肽𨯙嚙賜�嚙踝蕭臐�鳴蕭�莎蕭撠𩤃蕭臐�航𨯙��躰郭嚙踢岸��𨯙��辷蕭
��躰�肽𨯙��躰�肽𨯙嚙賡做嚙踢╱ｇ蕭暻芸�躰腺�𧊋臐�航𨯙��躰�肽𨯙
嚙踝蕭��嚙質�磰𨯙��躰�肽𨯙嚙賢䐓��躰釭臐�嚙踝蕭嚙踝蕭��辷蕭
��躰釭嚙賢��𨯙嚙踢�鍦�躰�栶�笔�辷蕭
��躰都嚙賢�躰腺嚙賬���躰腺嚙賢��
��躰酗��𥕦�躰郭��嚙賢��𨯙��鮋ㄙ
��躰都嚙賢�躰腺嚙賬���躰�肽𨯙��躰�肽𨯙��辷蕭
��躰都嚙賢�躰腺嚙賬�嚙踝蕭嚙質𨯙��躰�肽𨯙
��躰酗藆�坿���嚙質�𨅯�𡑒��𨯙��辷蕭
��躰酗��𨥈蕭嚙踢�航𨯙嚙踝蕭嚙踝蕭臐��𨯙
嚙踢坎萘���朞𨯙�坾蝞�嚙賢�躰�肽𨯙��辷蕭
��躰閉瘣賢�躰酗嚙踢�航𨯙�����𨯙��辷蕭
嚙踢△�嚙踝蕭嚙質𨯙嚙踝蕭璇寡𨯙��辷蕭
��躰�肽𨯙��躰腺銝滚��𨯙��躰�肽𨯙��躰�肽𨯙
��躰�肽𨯙��𥕦�页蕭���𧒆䕘蕭薴ㄟ��躰腺��舘�舘𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踢�𦴣��躰�肽𨯙��躰�肽𨯙
��躰閉�蕟��躰�肽𨯙��嚙踝蕭�𨯙��琜蕭藃�讛𨯙��辷蕭
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰�肽𨯙��躰�肽𨯙
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰部薴钟��辷蕭
��躰腺嚙賣�坿𨯙��嚙賣Ⅰ�𨯙��躰�肽𨯙��辷蕭
��躰腺嚙賣�坿𨯙��嚙賜�橘蕭嚙質�芷礆嚙�
嚙踝蕭臐号艟洽嚙踝蕭��磰𨯙��躰�肽𨯙��辷蕭
��躰�肽𨯙嚙賢𠘕嚙賢𠹭��㚁蕭銧游�辷蕭
��躰�肽𨯙��𥟇䠋�𨯙��躰�肽𨯙��𥪮�航𨯙
嚙踝蕭�緾嚙賢�躰郭嚙賭�𡑒𨯙嚙踝蕭嚙�
��躰�肽𨯙嚙踢╱Ｚ躀臐��𨯙��躰�肽𨯙��辷蕭
嚙踝蕭艟妟��𥕦�躰郭嚙賭�𤏸𨯙��躰�肽𨯙��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭嚙踝蕭�佞𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭擗�𠯫�𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭憍辷蕭�莎蕭嚙質鷄嚙踝蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜脩腦嚙踢𧒆��辷蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜賂蕭�樹𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰釭蝮�蕭�𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰郭嚙賜�樹𧒆��辷蕭
��躰腺�亙�滩𨯙��躰�頣蕭��𡏭𨯙��躰�肽𨯙�����痹蕭嚙�
��躰�肽𨯙嚙踢𧒆䕘蕭嚙踢孜讛𨯙��躰�肽𨯙��辷蕭
嚙踝蕭���蕭�䁥滩𨯙��琜蕭�迚�𨯙��辷蕭
��躰�肽𨯙��躰郭�𨺗��躰�肽𨯙
��躰�肽𨯙��躰�肽𨯙嚙踝蕭隤抵���嚙賬答�𨯙��躰�肽𨯙
可寧衛(8422)
月營收
季盈餘
2025/02/01
185.5元 (可寧衛股價)
2025/02/01
45.80% (年增率)
495百萬元 (營收)
可寧衛(8422) 年度營收走勢圖
12
291百萬/月 (110年)
469百萬/月 (111年)
342百萬/月 (112年)
478百萬/月 (113年)
N/A百萬/月 (114年)
可寧衛(8422)月營收明細
單位：仟元
年/月
營收
月增率
去年同期
年增率
累計營收
年增率
114/02
494,802
4.32%
339,377
45.80%
969,096
30.80%
114/01
474,294
-0.90%
401,539
18.12%
474,294
18.12%
113/12
478,619
-2.69%
342,909
39.58%
5,169,586
20.93%
113/11
491,840
50.75%
382,583
28.56%
4,690,967
19.31%
113/10
326,256
-3.32%
333,528
-2.18%
4,199,127
18.31%
113/09
337,460
-24.58%
310,817
8.57%
3,872,872
20.43%
113/08
447,422
25.15%
211,596
111.45%
3,535,412
21.70%
113/07
357,500
-14.56%
158,104
126.12%
3,087,990
14.65%
113/06
418,439
-15.28%
372,105
12.45%
2,730,489
7.70%
113/05
493,888
-8.00%
508,452
-2.86%
2,312,050
6.88%
113/04
536,818
-0.67%
365,641
46.82%
1,818,163
9.88%
113/03
540,428
59.24%
361,618
49.45%
1,281,345
-0.60%
113/02
339,377
-15.48%
463,608
-26.80%
740,916
-20.11%
113/01
401,539
17.10%
463,846
-13.43%
401,539
-13.43%
112/12
342,909
-10.37%
469,958
-27.03%
4,274,809
-18.55%
112/11
382,583
14.71%
536,401
-28.68%
3,931,900
-17.71%
112/10
333,528
7.31%
447,848
-25.53%
3,549,317
-16.33%
112/09
310,817
46.89%
519,688
-40.19%
3,215,789
-15.24%
112/08
211,596
33.83%
488,257
-56.66%
2,904,972
-11.28%
112/07
158,104
-57.51%
398,929
-60.37%
2,693,376
-3.33%
112/06
372,105
-26.82%
431,881
-13.84%
2,535,271
6.20%
112/05
508,452
39.06%
411,106
23.68%
2,163,166
10.63%
112/04
365,641
1.11%
423,002
-13.56%
1,654,714
7.15%
112/03
361,618
-22.00%
383,646
-5.74%
1,289,072
14.97%
112/02
463,608
-0.05%
345,028
34.37%
927,454
25.74%
112/01
463,846
-1.30%
392,560
18.16%
463,846
18.16%
111/12
469,958
-12.39%
291,211
61.38%
5,248,304
73.48%
111/11
536,401
19.77%
294,300
82.26%
4,778,346
74.77%
111/10
447,848
-13.82%
266,247
68.21%
4,241,945
73.87%
111/09
519,688
6.44%
276,644
87.85%
3,794,097
74.56%
111/08
488,257
22.39%
263,766
85.11%
3,274,409
72.62%
111/07
398,929
-7.63%
222,122
79.60%
2,786,152
70.61%
111/06
431,881
5.05%
167,734
157.48%
2,387,223
69.19%
111/05
411,106
-2.81%
194,161
111.73%
1,955,340
57.28%
111/04
423,002
10.26%
232,095
82.25%
1,544,235
47.20%
111/03
383,646
11.19%
306,590
25.13%
1,121,234
37.24%
111/02
345,028
-12.11%
277,211
24.46%
737,587
44.52%
111/01
392,560
34.80%
392,560
110/12
291,211
-1.05%
3,025,250
110/11
294,300
10.54%
2,734,039
110/10
266,247
-3.76%
2,439,739
110/09
276,644
4.88%
2,173,492
110/08
263,766
18.75%
1,896,848
110/07
222,122
32.43%
1,633,082
110/06
167,734
-13.61%
1,410,960
110/05
194,161
-16.34%
1,243,226
110/04
232,095
-24.30%
1,049,065
110/03
306,590
10.60%
816,970
說明：自2013年起上市櫃公司因IFRSs會計準則規範，每月公告的營收必須是合併營收，不再公告非合併營收。2012年(含)前，合併營收是採自願公告。
